Patents by Inventor Michael Southern

Michael Southern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
    Patent number: 11518765
    Abstract: The present invention describes compounds of formula (I) Wherein: R1 is selected from H and CH3 R2 is selected from H, C4H9 alkyl, C6H13 alkyl and C3H6-phenyl, said phenyl optionally substituted by OH or OCH3, (1R,2S,5S)-5-methylcyclopent-3-ene-1,2-diol X is O or S Y is C, N or S. These compounds have been identified as novel compounds useful in the treatment of multiple sclerosis and other autoimmune diseases.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: December 6, 2022
    Assignee: THE PROVOST, THE FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
    Inventors: John Michael Southern, Stephen J. Connon
  • SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20210024529
    Abstract: The present invention describes compounds of formula (I) Wherein: R1 is selected from H and CH3 R2 is selected from H, C4H9 alkyl, C6H13 alkyl and C3H6-phenyl, said phenyl optionally substituted by OH or OCH3, (1R,2S,5S)-5-methylcyclopent-3-ene-1,2-diol X is O or S Y is C, N or S. These compounds have been identified as novel compounds useful in the treatment of multiple sclerosis and other autoimmune diseases.
    Type: Application
    Filed: August 27, 2020
    Publication date: January 28, 2021
    Inventors: John Michael SOUTHERN, Stephen J. CONNON
  • Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
    Patent number: 10793572
    Abstract: Disclosed are novel compounds useful in the treatment of multiple sclerosis and other autoimmune diseases. The present invention describes compounds of formula (I) wherein: R1 is selected from H and CH3 R2 is selected from H, C4H9 alkyl, C6H13 alkyl and C3H6-phenyl, said phenyl optionally substituted by OH or OCH3, (1R,2S,5S)-5-methylcyclopent-3-ene-1,2-diol X is O or S Y is C, N or S.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: October 6, 2020
    Assignee: THE PROVOST FELLOWS FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH
    Inventors: John Michael Southern, Stephen J. Connon
  • SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20170240553
    Abstract: Disclosed are novel compounds useful in the treatment of multiple sclerosis and other autoimmune diseases. The present invention describes compounds of formula (I) wherein: R1 is selected from H and CH3 R2 is selected from H, C4H9 alkyl, C6H13 alkyl and C3H6-phenyl, said phenyl optionally substituted by OH or OCH3, (1R,2S,5S)-5-methylcyclopent-3-ene-1,2-diol X is O or S Y is C, N or S.
    Type: Application
    Filed: September 29, 2015
    Publication date: August 24, 2017
    Inventors: John Michael SOUTHERN, Stephen J. CONNON
  • Movement control screed
    Patent number: 8584416
    Abstract: Various embodiments of the present invention are directed to a movement control screed that is structured for installation between first and second masonry coatings applied adjacent to a building wall. The movement control screed is structured as a control joint for absorbing movement between the first and second masonry coatings and also as a weep screed for accommodating drainage of water from behind the masonry coatings. The movement control screed comprises first and second flanges provided on opposite sides of first and second ribs.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: November 19, 2013
    Inventors: Gary Chenier, Michael Southern
  • Movement control screed
    Publication number: 20070130861
    Abstract: Various embodiments of the present invention are directed to a movement control screed that is structured for installation between first and second masonry coatings applied adjacent to a building wall. The movement control screed is structured as a control joint for absorbing movement between the first and second masonry coatings and also as a weep screed for accommodating drainage of water from behind the masonry coatings. The movement control screed comprises first and second flanges provided on opposite sides of first and second ribs.
    Type: Application
    Filed: December 2, 2005
    Publication date: June 14, 2007
    Inventors: Gary Chenier, Michael Southern